|
Volumn 80, Issue 8, 2001, Pages 492-495
|
Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient
|
Author keywords
Thalassemia major; Recombinant human erythropoietin
|
Indexed keywords
DEFEROXAMINE;
DIGOXIN;
ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;
ENDOTHELIN 3;
FERROUS SULFATE;
FOLIC ACID;
HEMOGLOBIN F;
INTERCELLULAR ADHESION MOLECULE 1;
RECOMBINANT ERYTHROPOIETIN;
TESTOSTERONE;
VASCULAR CELL ADHESION MOLECULE 1;
ADULT;
ALLOIMMUNIZATION;
ANEMIA;
ARTICLE;
BLOOD TRANSFUSION;
CARDIOMYOPATHY;
CASE REPORT;
CELL DIFFERENTIATION;
CELL PROLIFERATION;
CHELATION THERAPY;
DRUG TOLERABILITY;
ERYTHROID CELL;
HUMAN;
HYPOGONADISM;
MALE;
OSTEOPOROSIS;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SIDE EFFECT;
SPLENECTOMY;
THALASSEMIA MAJOR;
ADULT;
BETA-THALASSEMIA;
BLOOD TRANSFUSION;
ERYTHROPOIETIN;
HUMANS;
ISOANTIBODIES;
MALE;
RECOMBINANT PROTEINS;
|
EID: 0034883768
PISSN: 09395555
EISSN: None
Source Type: Journal
DOI: 10.1007/s002770100317 Document Type: Article |
Times cited : (19)
|
References (20)
|